Halozyme Therapeutics, Inc.

EP Wealth Advisors, LLC HALO

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/18/2026

Shares

8,803

Value ($000)

592

Weight

0.0%

2019 Q4 - 2025 Q4 (20 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/18/2026	592	0.0%	8,803	12/31/2025
2025 Q2	8/14/2025	432	0.0%	8,303	6/30/2025
2025 Q1	5/15/2025	534	0.0%	8,375	3/31/2025
2024 Q4	2/14/2025	324	0.0%	6,769	12/31/2024
2024 Q3	11/15/2024	357	0.0%	6,236	9/30/2024
2023 Q4	2/28/2024	203	0.0%	5,500	12/31/2023
2023 Q3	11/24/2023	211	0.0%	5,516	9/30/2023
2023 Q1	6/5/2023	212	0.0%	6,685	3/31/2023
2022 Q4	6/12/2023	314	0.0%	5,514	12/31/2022
2022 Q2	8/11/2022	242	0.0%	5,500	6/30/2022
2022 Q1	5/20/2022	339	0.0%	8,500	3/31/2022
2021 Q4	2/17/2022	342	0.0%	8,500	12/31/2021
2021 Q3	11/23/2021	346	0.0%	8,500	9/30/2021
2021 Q2	8/24/2021	386	0.0%	8,500	6/30/2021
2021 Q1	5/17/2021	354	0.0%	8,500	3/31/2021
2020 Q4	2/18/2021	363	0.0%	8,500	12/31/2020
2020 Q3	11/17/2020	223	0.0%	8,500	9/30/2020
2020 Q2	8/14/2020	268	0.0%	0	6/30/2020
2020 Q1	5/18/2020	180	0.0%	10,000	3/31/2020
2019 Q4	2/14/2020	177	0.0%	10,000	12/31/2019